1. Home
  2. CNTX vs MHH Comparison

CNTX vs MHH Comparison

Compare CNTX & MHH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CNTX
  • MHH
  • Stock Information
  • Founded
  • CNTX 2015
  • MHH 1986
  • Country
  • CNTX United States
  • MHH United States
  • Employees
  • CNTX N/A
  • MHH N/A
  • Industry
  • CNTX Biotechnology: Pharmaceutical Preparations
  • MHH Professional Services
  • Sector
  • CNTX Health Care
  • MHH Consumer Discretionary
  • Exchange
  • CNTX Nasdaq
  • MHH Nasdaq
  • Market Cap
  • CNTX 75.6M
  • MHH 86.6M
  • IPO Year
  • CNTX 2021
  • MHH N/A
  • Fundamental
  • Price
  • CNTX $1.13
  • MHH $7.35
  • Analyst Decision
  • CNTX Strong Buy
  • MHH
  • Analyst Count
  • CNTX 7
  • MHH 0
  • Target Price
  • CNTX $5.20
  • MHH N/A
  • AVG Volume (30 Days)
  • CNTX 260.4K
  • MHH 10.8K
  • Earning Date
  • CNTX 11-05-2025
  • MHH 11-05-2025
  • Dividend Yield
  • CNTX N/A
  • MHH N/A
  • EPS Growth
  • CNTX N/A
  • MHH N/A
  • EPS
  • CNTX N/A
  • MHH 0.07
  • Revenue
  • CNTX N/A
  • MHH $200,000,000.00
  • Revenue This Year
  • CNTX N/A
  • MHH N/A
  • Revenue Next Year
  • CNTX N/A
  • MHH $3.78
  • P/E Ratio
  • CNTX N/A
  • MHH $99.56
  • Revenue Growth
  • CNTX N/A
  • MHH 5.16
  • 52 Week Low
  • CNTX $0.49
  • MHH $6.20
  • 52 Week High
  • CNTX $2.59
  • MHH $16.00
  • Technical
  • Relative Strength Index (RSI)
  • CNTX 69.12
  • MHH 41.74
  • Support Level
  • CNTX $0.98
  • MHH $7.48
  • Resistance Level
  • CNTX $1.29
  • MHH $7.75
  • Average True Range (ATR)
  • CNTX 0.09
  • MHH 0.29
  • MACD
  • CNTX 0.02
  • MHH -0.05
  • Stochastic Oscillator
  • CNTX 65.91
  • MHH 5.17

About CNTX Context Therapeutics Inc.

Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.

About MHH Mastech Digital Inc

Mastech Digital Inc is a provider of Digital Transformation IT Services. The Company offers data & analytics solutions & IT staffing services for both digital & mainstream technologies. The Group has two segments. Its Data & Analytics Services segment delivers specialized data management, data engineering, customer experience consulting, data analytics & cloud services to customers globally. IT Staffing Services segment combines technical expertise with business process experience to deliver a broad range of services in digital & mainstream technologies. The company derives a majority of its revenue from IT staffing services. Geographically, the majority of revenue is generated from the United States.

Share on Social Networks: